LYTIR

Company · QNRX

Quoin Pharmaceuticals, Ltd.

Nasdaq's symbol directory lists QNRX on Nasdaq as “Quoin Pharmaceuticals, Ltd. - American Depositary Shares”: an American depositary receipt, a certificate traded in the US for shares of a foreign company.

In the 12 months to Nov 8, 2026: insiders bought on 4 occasions ($280K); 1 filing by holders of 5% or more; 6 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Denise P. Carter, Chief Operating Officer bought on 1 day latest Aug 31, 2026 bought $100K
  2. Michael Myers, Chief Executive Officer bought on 1 day latest Aug 31, 2026 bought $100K
  3. Sally Bridget Lawlor, Chief Financial Officer bought on 1 day latest Aug 31, 2026 bought $50K
  4. Anthony James Culverwell bought on 1 day latest Aug 31, 2026 bought $30K
Every trade (4)
  1. BUYDenise P. Carter, Chief Operating Officer bought Aug 31, 2026 20,490 shares filing $100K
  2. BUYMichael Myers, Chief Executive Officer bought Aug 31, 2026 20,490 shares filing $100K
  3. BUYSally Bridget Lawlor, Chief Financial Officer bought Aug 31, 2026 10,244 shares filing $50K
  4. BUYAnthony James Culverwell bought Aug 31, 2026 6,146 shares filing $30K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Ikarian Capital, LLC filed Oct 7, 2026 Schedule 13G/A passive filing 4.4%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition filing Nov 6, 2026
  2. Entry into a material definitive agreement filing Nov 4, 2026
  3. Regulation FD disclosure; Other events filing Oct 20, 2026
  4. Regulation FD disclosure; Other events filing Oct 14, 2026
  5. Regulation FD disclosure; Other events filing Sep 22, 2026
  6. Regulation FD disclosure; Other events filing Sep 10, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.